CXCL10 and systemic sclerosis: A retrospective study showed that serum CXCL10 levels are increased in preclinical (nonfibrotic)/early SSc patients and that high concentrations of CXCL10 indicate a faster rate of progression from preclinical/early SSc to worse disease stages [90].